Norton vs. Kaspersky

Norton and Kaspersky share strong detection scores in independent tests, but they are built around entirely different product philosophies — and one carries a geopolitical trust question that the other does not.

Norton is a US company that built a security suite: antivirus paired with VPN, password manager, identity monitoring, and backup. Kaspersky is a Russian company that built one of the most technically capable antivirus engines in the world. For US residents, the comparison ends at the first observation: new Kaspersky sales are banned by the US Commerce Department as of September 2024.

For US residents, Norton is the only option. Kaspersky's new-sale ban is in effect and cannot be worked around.

For users outside the US, the comparison becomes a genuine trade-off: Norton's suite approach versus Kaspersky's detection-first focus — with the Kaspersky trust question as a factor that needs to be actively evaluated, not ignored.

If the trust question is unresolved for you, Norton is the default.

Norton's philosophy is coverage: protect the user across multiple threat surfaces with a single subscription. The antivirus component is strong, but it shares product space with VPN, identity monitoring, cloud backup, and parental controls. Whether that suite logic applies to you determines whether Norton is the right product or just an expensive antivirus.

Kaspersky's philosophy is technical excellence at the core job: blocking threats before they execute, with behavioral detection and threat intelligence that consistently scores at the top of independent benchmarks. The product doesn't try to be a suite. It tries to be the best antivirus.

The philosophical split is clear. Norton optimises for consolidation. Kaspersky optimises for detection depth. The trust question adds a dimension that pure product philosophy doesn't capture.

Kaspersky's trust problem is structural. Russian legal frameworks create obligations to state intelligence services that corporate policy language cannot override. The US Commerce Department ban, German BSI advisory, and other government actions are responses to this structural concern — not to any confirmed security incident.

Norton is a US company (Gen Digital) with its own legal obligations to US intelligence, which some users weigh against Kaspersky's Russian obligations. For users for whom both create concern, European alternatives like Bitdefender, ESET, or F-Secure address the jurisdiction question entirely.

The obvious case for Norton is: trusted US company with a comprehensive suite. That breaks if you only want antivirus — the suite overhead is real, and Kaspersky (where available and trusted) delivers stronger detection at a lower price without the bundled components you may not use.

The obvious case for Kaspersky is: best technical detection outside the US. That breaks when the trust question can't be resolved for your context. No detection advantage justifies a structural trust risk in sensitive professional environments.

US residents: Norton by default — Kaspersky's new-sale ban is in effect.

Non-US users who want the suite logic: Norton 360, if the bundled components would actually be used.

Non-US users who want focused detection and have explicitly evaluated the trust question: Kaspersky remains a technically excellent product for those who've made that call.

Norton and Kaspersky solve different problems. Norton is the bundle for users who want coverage across multiple threat surfaces. Kaspersky is the detection-first product for users who've weighed the trust dimension and concluded it doesn't apply to them.

For most users, the trust question alone resolves this comparison. For the rest, the suite vs. focused distinction takes over.